Press Releases

Press releases ordered by year

• 2010

  • June 23, 2010

    Prosensa and GlaxoSmithKline initiate development of four additional products under existing alliance in Duchenne Muscular Dystrophy.

  • March 30, 2010

    Prosensa initiates clinical development of PRO044 in an open label phase I/II study - Prosensa’s second clinical candidate for treatment of Duchenne Muscular Dystrophy

  • March 17, 2010

    Prosensa strengthens its management team - Berndt Modig appointed as Chief Financial Officer

• 2009

  • October 13, 2009

    Prosensa and GlaxoSmithKline form alliance to fight Duchenne Muscular Dystrophy

  • September 30, 2009

    Prosensa and LUMC strengthen strategic alliance through broadened RNA modulation license agreement

  • September 14, 2009

    Prosensa’s RNA based therapeutic PRO051 shows favourable results in the first systemic study in patients with Duchenne Muscular Dystrophy

  • September 8, 2009

    Prosensa to Present Data at the World Muscle Society Congress

  • August 31, 2009

    Prosensa and TREAT-NMD enter into strategic collaboration for PRO-051 clinical trial planning

  • August 17, 2009

    Prosensa receives notice of allowance for key patent related to lead compound in development for Duchenne Muscular Dystrophy

  • July 24, 2009

    Prosensa appoints new Chief Medical Officer

  • February 26, 2009

    Prosensa strengthens management team

• 2008

  • December 17, 2008

    Prosensa raises EUR 18 million Series B financing

  • May 6, 2008

    Prosensa strengthens board with two new board members

  • May 5, 2008

    Prosensa announces the start of an international multi-center phase I/II clinical study with ‘smart drug’ PRO051 in patients with Duchenne Muscular Dystrophy

• 2007

  • December 27, 2007

    Leiden University Medical Center and Prosensa B.V. Announce New England Journal of Medicine Publication of First Successful Clinical Study with RNA-based Therapeutic PRO051 in Duchenne Muscular Dystrophy

  • February 9, 2007

    Prosensa strengthens key team by appointing Head of Research

  • January 5, 2007

    Prosensa raises $18 million Series A financing led by LSP and Abingworth